NCT03237117View on ClinicalTrials.gov

Effect of Growth Hormone on Uterine Receptivity in Women With RIF in an Oocyte Donation Program

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

January 1, 2010

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Female Infertility
Interventions
BIOLOGICAL

Growth Hormone (GH)

to evaluate the effect of GH administration in the donated oocyte recipient program among women with RIF (repeated implantation failure)

Trial Locations (1)

18016

RECRUITING

University of Granada, Granada

Sponsors
All Listed Sponsors
collaborator

Universidad de Granada

OTHER

lead

Competence Centre on Health Technologies

OTHER